Friday, January 27, 2006

 

Plaintiff's paradise waits for latest Vioxx trial

 

Plaintiff's paradise waits for latest Vioxx trial
Centre Daily Times - Centre County,PA,USA
... bypass. But his lawyers who are suing Merck & Co. say it was the Vioxx that he took for arm pain for 17 days that killed him. Jury ...

Did Barnes Firm lawyer tell the whole truth?
Buffalo News - NY, United States
After the painkiller Vioxx was pulled from the market in September 2004, the Cellino & Barnes law firm featured its medical star in television ads aimed at ...

Jury pool remains adequate for Vioxx retrial, judge says
TheNewsTribune.com (subscription) - Tacoma,WA,USA
Although New Orleans has fewer than half the residents it did before Hurricane Katrina, the judge hearing the first federal Vioxx trial has told attorneys he ...  

Pfizer quarter beats forecasts
ShareCast - London,UK
... 71%, hypertension drug Accupril sank 74%, while sales of arthritis treatment Celebrex tumbled 53% following the recall of Merck's similar drug Vioxx in 2004. 

Journal editors to be deposed ahead of next Vioxx trials
Centre Daily Times - Centre County,PA,USA
for withholding data from a published study on its withdrawn painkiller Vioxx, will be grilled next week by the company's lawyers. ...

'Vioxx like' drugs may still be best option for arthritis write ...
Imperial College London - London,UK
Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of ...  

 Vioxx faces 2 federal suits
Jackson Clarion Ledger - Jackson,MS,USA
NEW ORLEANS -- The next two federal lawsuits claiming that the painkiller Vioxx caused heart attacks or other cardiovascular problems are scheduled for trial ...

Next Vioxx Cases Scheduled for Spring
Ely Times - NV, USA
NEW ORLEANS - The next two federal lawsuits claiming that the painkiller Vioxx caused heart attacks or other cardiovascular problems are scheduled for trial ...

Next two Vioxx trials to begin this spring
Asbury Park Press - Asbury Park,NJ,USA
The next two federal lawsuits claiming that Vioxx caused heart attacks or other cardiovascular problems are scheduled for trial this spring. ...


Sunday, January 22, 2006

 

Blood Clots, Heart Attacks, Strokes Linked to Elevated C-Reactive Protein

Blood Clots, Heart Attacks, Strokes, Spontaneous Pre Term Births, Low Birth Weight, Rectal Cancer, Diabetes, are all Linked to Elevated C-Reactive Protein
Edited by Carly Zander
Staff Writer, Send2Press.com
   

4 Nov 2005 - CHICAGO, IL (SEND2PRESS NEWSWIRE) -- The first study of its kind, not only linking high C-reactive protein levels to periodontal (gum) disease but also the most effective new treatment to drastically and quickly reduce deadly C-reactive levels will be given by dentist Dr. Ron Schefdore at the prestigious Mid Winter Chicago Dental Society meeting in Feb '06. Surprisingly the study analyzed C-reactive protein blood results from top dentists throughout the country in a study to find the least painful and inexpensive treatment.

This is great news for the estimated 50% of Americans that do not go to the dentist because of fear or affordability to care. Currently people go through painful and expensive periodontal surgery, a mouth full of tooth extractions, or are taking dangerous Statin drug therapy to try and lower deadly C-reactive protein levels.

Heart attack and stroke are the biggest killers in the US; we have been focusing on the wrong indicator (cholesterol) to lower risk of a heart attack and stroke. The same bacteria in the mouth that causes calcium buildup around the teeth (tartar or calculus) were also found embedded in the calcium buildup in the arteries around the heart (arteriosclerosis) in a recent study. According to the ADA, inflamed gums affect 250 million Americans.

"Most of these people are at risk with elevated C-reactive protein levels that can easily be controlled with this new method," says Schefdore. "Afro-Americans and Hispanic Americans have the highest incidence of gum disease and - coincidently - have the highest incidence of heart disease and diabetes. Periodontal disease is now an epidemic and we need a simple, non painful and economical way for people to control this disease that can rob people of their life and good health."

People do not ever have to floss again to have healthy gums on Schefdore's program. "Be honest," he says, "do you floss correctly everyday?"

Blood tests confirmed that Schefdore's non-flossing and pain-free, inexpensive dental treatment lowers C-reactive protein levels better and faster than painful and expensive traditional dental methods, or potentially dangerous Statin drugs. It is very simple, 75% less in cost, and a lot less painful.


For information on the Chicago Dental Society Midwinter meeting, visit: http://www.cds.org/

Wednesday, January 18, 2006

 

Popular Trade Publications: DV Magazine, eWeek, plus many more free subscriptions

 Subject: Popular Trade Publications: DV Magazine, CADBlocks, plus many more ...

Greetings!

All the publications below are available to you since you live in the United States. We hope you will find them of interest. Click on the titles below to see if you qualify, and be sure to forward this email to business associates - they may wish to apply to receive a complimentary publication in their industry as well.

Subscribe and enjoy!

 
Popular Trade Publications at TradePub.com

DV Magazine
provides objective, hard-hitting, in depth reviews of digital video ...
more info
  CADBlocks
targets architects, specifying engineers, and CAD Managers ...
more info
  eWeek
enables readers to successfully evaluate, deploy and ...
more info
 
Other Reader Favorites:

Refocus
reports on all the major developments in renewable energy ...
more info
  Biophotonics International
delivers a unique global insight into the photonic products ...
more info
  Dr. Dobb's Journal
enables programmers to write the most efficient and ...
more info
 
Baseline
provides the practical information needed to undertake ...
more info
  Investment Advisor features product surveys, planner profiles, and ...
more info
  Small Times
spotlights key issues in nanotechnology, MEMS and microsystems ...
more info
 

Remember, all subscriptions are complimentary to industry professionals who meet the publishers' qualifying criteria. If you missed last week's newsletter, please click here to see it now.

Cheers!

Gina Geertz
TradePub.com Manager
gina@TradePub.com
www.TradePub.com

Frequently Asked Questions

Are trade publications really FREE and why?
Yes! All of the trade publications on the TradePub.com Websites are absolutely free of charge. There are no hidden fees, and there is no obligation. TradePub.com will not invoice for subscriptions.

Doing business in today's competitive environment requires a serious commitment to stay abreast of trends and technology, and every business needs a technology infrastructure to perform effectively and efficiently. Trade publications and their advertisers want to give you information you need to do business. It's worth it to them to give you the magazine free because you have a genuine need for the information and products described therein. Advertisers need a vehicle to deliver their message to you which justifies spending advertising dollars to give subscriptions for free.

How long will it take to get my first issue?
If the publisher determines your subscription is qualified, it may take up to twelve (12) weeks for the publisher or their fulfillment agent to deliver your first issue, however it varies, and may also depend on where your subscription application falls in their circulation cycle.

How will I know if I've qualified to receive the free trade publication?
All qualification forms are forwarded to the publishers. It is the sole discretion of the publisher to determine if they will accept or deny subscriptions. Unfortunately publishers do not always have a procedure to notify subscribers if they are not accepted. If the 12 week time frame has passed and you have not received your first issue, you may want to try selecting another publication of similar interest - different publishers may have different qualifying standards for each publication. You may also want to refer to the thank-you email that was sent to you when you submitted the qualification form. There you will find the contact information for directing your subscription status inquiries.

What if I am looking for a magazine that is not listed?
We add publications to our Website on a regular basis. If you join our email list, you will be periodically notified of any new publications that are added to our site.

If I live outside of the U.S., can I qualify to get trade publications?
The publishers determine the countries that are eligible for free subscriptions. Some publishers have an international edition available. Unfortunately, TradePub.com cannot make any exceptions. You may view the publication list by geographic eligibility by clicking here.

What if my mailing address changes during my subscription?
You will need to contact the publisher directly to change your address. For publisher contact information, refer to the masthead in the first few pages of the print magazine, or search online.

Who do I contact if I want to find out about editorial calendars, publication advertising, or other content for a specific trade magazine?
You will need to contact publishers directly to get editorial, advertising or partnership program information on individual publications. NetLine Corporation does not publish any of the titles listed on the Consultant-Directory.TradePub.com website. You can typically find the publisher contact information on the table of contents page or in the first few pages of the print publication.


What qualifications do I need to receive a free subscription to a trade publication?
The publishers are solely responsible for determining the specific requirements needed to receive their publications free of charge. TradePub.com is not involved in this decision, nor does TradePub.com have any influence on what this criteria is. Generally, one or more of the following is required: 1. your work requires you to be informed and up-to-date about the subject matter covered by the trade publication, 2. you need information about the types of products that are advertised or discussed in the trade publication, and/or 3. you evaluate, recommend and/or purchase types of products that are advertised or discussed in a trade publication. Publishers are interested in specific job titles and job functions, but may also evaluate and determine qualification based on other criteria asked in their qualification form. Additionally, publishers' criteria may change from time to time, based on their overall demographic needs and requirements.

How long will my free subscription(s) last?
Publishers determine the length of the subscription period for each publication. Most free subscriptions last at least a year. When the publisher's circulation period is over, however, they may ask you to requalify in order to continue receiving their magazine. Again, these are not soft offers and you will not receive an invoice for your subscription.

Is Consultant-Directory.TradePub.com the publisher?
Consultant-Directory.TradePub.com is not the publisher of the magazines on this Website or any partner sites. We collect qualified (free) subscriptions on behalf of our publishing clients. For editorial, magazine advertising, circulation, or other inquiries, you will need to contact the publishers directly.

Why do the qualification forms ask a personal question?
Most publishers work with third party agencies that audit their circulation numbers. These agencies require that subscribers answer a personal verification question to be used during audits to verify that the person filling out the form is indeed who they claim to be. On a standard paper-based qualification form, the publisher would ask for a signature, however since that is not possible to do online, this is the industry accepted alternative.

I'm a Circulation Manager or publisher and would like to list my magazine on a TradePub.com site - how can I do this?
For information about our subscriber acquisition services, please email your inquiry to pubsales@TradePub.com.

Consultant-Directory.TradePub.com is a division of NetLine Corporation - please tell me more about NetLine.
NetLine is a marketing automation service provider that combines powerful technology with proven "best practices" to help business-to-business marketers leverage the Internet for lead generation, relationship marketing, and building marketing intelligence. Our services are quite varied and include everything from email newsletters and event follow-up programs to email list rental, online registration pages, and most importantly, the backend tracking, reporting, and analysis of these efforts to validate their effectiveness.

NetLine, an innovator in Internet marketing since 1994, is located in Los Gatos, CA.

 
 
 

Monday, January 16, 2006

 

Drug profits infect medical studies

 

Drug profits infect medical studies
Los Angeles Times - CA,USA
He is a consultant to attorneys of patients who took Vioxx and are suing Merck. ... There is no better cautionary tale than the unwarranted success of Vioxx. ...

Vioxx case set in Starr County
Monitor - McAllen,TX,USA
RIO GRANDE CITY -- The nation's fourth lawsuit against Merck & Co.'s Vioxx painkiller, linked to heart problems, is set for jury selection Jan. ...

Expert Opinion on Drug Safety Launches an Open-Access ...
Yahoo! News (press release) - USA
LONDON, January 6 /PRNewswire/ -- Since the withdrawal of Vioxx, issues surrounding drug safety, adverse events and pharmacovigilance have become more ...  

Merck Vioxx Judge Threatens to End Suit Consolidation (Update2)
Bloomberg - USA
Jan. 5 (Bloomberg) -- The judge overseeing federal lawsuits over Merck & Co.'s Vioxx painkiller said he may end his effort to combine the cases for a possible ...

Truth in advertising; service packaging; 'tingi' marketing
INQ7.net - Philippines
... Take the case of Merck's Vioxx, the acute pain killer and anti-arthritis medication that had to be withdrawn from the market because Merck, or more precisely ...

Merck shares dip after downgrade
MarketWatch - USA
... Sales are still reeling from the Whitehouse Station, NJ-based company's decision in 2004 to pull its Vioxx pain-killer off shelves for fear it could cause ...

Genetics Plays Role in Side Effects Associated With Painkillers
EndoNurse - Phoenix,AZ,USA
The study looked at people taking two popular painkillers --rofecoxib (Vioxx, Merck) and celecoxib (Celebrex, Pfizer) -- known as COX-2 inhibitors. ...   

Walgreen's 1Q profit jumps 5%
CNN/Money - USA
... New York Stock Exchange. Copycats like Lipitor can make billions, or fail like Vioxx and Bextra. (Full story). The retailer, which ...  


Friday, January 13, 2006

 

Second Texas Vioxx trial slated for January

 

Second Texas Vioxx trial slated for January
Reuters - USA
NEW YORK (Reuters) - Merck & Co. (MRK.N: Quote, Profile, Research), which lost its first Vioxx product liability case last summer in Texas, on Tuesday said a ...

Drugs in '05: Much Promise, Little Payoff
New York Times - United States
... industry executives to complain that the FDA is denying approval to good new treatments because of the criticism the agency has faced from lawmakers over Vioxx ...

Second Texas Vioxx Trial to Start Jan. 24
FOX News - USA
NEW YORK -- Merck & Co. (MRK), which lost its first Vioxx product liability case last summer in Texas, Tuesday said a trial involving another Texas Vioxx user ...

VIOXX(R) Trial Update: Statement on VIOXX(R) Product Liability ...
Genetic Engineering News - Larchmont,NY,USA
... The company believes the evidence in this case will show that VIOXX did not cause the unfortunate heart attack of Leonel Garza, Sr. ...

Fourth Vioxx Trial Set for The Valley
Texas Lawyer (subscription) - TX,USA
A jury in the Rio Grande Valley in Texas, a traditionally plaintiff-friendly location, will hear the nation's next Vioxx suit. The ...

Fourth Vioxx case set for Jan. 24
CNN/Money - USA
New Vioxx case to be held in Texas, while mistrial will be retried next month in New Orleans. By Aaron Smith, CNNMoney.com staff writer. ...

VIOXX(R) Trial Update: Statement on VIOXX(R) Product Liability ...
Finanzen.net - Germany
... years of cardiovascular disease and a prior heart attack.Approximately one month before his death, Mr. Garza was given aone-week supply of VIOXX 25 mg samples ... 

Stocks Rise Despite Smaller Intel Forecast
Newsday - Long Island,NY,USA
... of Medicine on Thursday said researchers failed to disclose that three patients suffered heart attacks in a 2000 Merck-funded study of its Vioxx painkiller. ...

The family business
Scientist - UK
Merck owes its victory in a recently concluded Vioxx trial in New Jersey largely to the testimony of J. Michael Gaziano, a Harvard cardiologist who expressed ...

Pharma's year of trouble and strife
Nature.com (subscription) - London,England,UK
The year began, much as 2004 had ended, with Vioxx (rofecoxib; Merck) and the other cyclooxygenase-2 (COX2) inhibitors dominating the headlines. ... 

Larry Sobal column: There's a mess beyond Vioxx
Appleton Post Crescent - WI, USA
Last month, it was all over the news that a US federal judge in Houston ruled that the latest trial involving Vioxx was a mistrial due to a hung jury. ...

Merck witness has chink in armor
Newark Star Ledger - Newark,NJ,USA
... Described by her bosses at the New Jersey pharmaceutical company as a "tenacious defender of the Vioxx franchise," she has been Merck's most reliable witness ... 
  


Tuesday, January 03, 2006

 

Chitika Account Suspension Notice (N) - Chitika Meltdown...?

I had my Chitika account suspended the other day (December 29, 2005) and they will not respond to the calls, emails, and support ticket I entered on their site.

I wanted to know what the problem was and try to resolve it, but they won't get in touch with me no matter what I do. So I am starting the big job of pulling all of their ads from the sites I added them to. Man, what a pain!

My sites weren't making much from them anyway, I think they owe me $30-$40, but I had been working to try and generate more traffic to the sites that have their ads. Now they pull this BS.

So if you were considering using Chitika on your site(s), I would recommend instead that you copy the style of ads they were using and try that with some good affiliate programs. The ad style seemed to be effective, but the company really, really sucks.

I thought I waited long enough to make sure it was going to be worth the trouble, but at least now some of you won't have to go through what I am. The program from Google is so far the easiest, the best run, and pays very well so I can recommend that you try that completely.

Don't take my word for it, do a search in Google for "chitika sucks" or "shitika" (Not to be confused with the mushroom with a similar name...) and you will find a few others that are not happy with what seemed like a good system.

(hris

Keywords: Chitika, Chitika ads, Chitika advertising, contextual ads, eminimalls, e-minimalls, e mini malls, web publishers, best deals, Impulse Merchandising, eMiniMall services, Venkat Kolluri, Alden DoRosario, Dave Andre, Russell Franks

This page is powered by Blogger. Isn't yours?

vertical search engines | niche search engines | search engines | vioxx | search-engines